Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments.

2 A), which displays a clear trend of high levels of lymphocyte progression, for calcifediol (Fig. 2 B), with protective effect already reported [ 6 ], supported also by high levels of lymphocyte progression, and, as a counterexample, furosemide, here linked to an increase in death risk, with lymphocyte levels below the average population (Fig. 2 C).

also in 19,460 other papers

It is important to note that other drugs, which are marginally non-significant because of small sample sizes, have also a potential negative effect on COVID-19 patient survival.

also in 1,493 other papers